Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,714 across all filing types
Latest filing 2015-10-08 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
募集资金管理办法（2015年10月）
Governance Information Classification · 95% confidence The document is titled '募集资金管理办法' which translates to 'Fundraising Capital Management Measures'. It is a detailed internal policy document outlining the management, use, supervision, and regulatory compliance related to the company's raised funds. It references relevant laws, regulatory rules, and internal governance procedures. The content is focused on the management and use of capital raised through securities issuance, including the establishment of special accounts, investment project feasibility, supervision, and reporting requirements. There is no indication that this is an announcement, a financial report, or a regulatory filing per se. It is a governance-related document detailing internal rules and procedures for managing raised capital. Therefore, the most appropriate classification is Governance Information (CGR).
2015-10-08 Chinese
非公开发行A股股票募集资金运用的可行性分析报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "Feasibility Analysis Report on the Use of Funds Raised from Non-public Issuance of A Shares" by 紫光古汉集团股份有限公司. It details the planned use of funds raised through a non-public share issuance, including investment projects, their descriptions, investment amounts, and expected impacts on the company. The content focuses on capital raising and the deployment of those funds into various projects, which aligns with a capital or financing update. There are no financial statements or comprehensive financial performance data typical of annual or interim reports. It is not an announcement of a report publication but a substantive report on fundraising and fund usage. Therefore, the document fits best under the category of Capital/Financing Update (CAP).
2015-10-08 Chinese
中德证券有限责任公司关于公司详式权益变动报告书之财务顾问核查意见
Major Shareholding Notification Classification · 95% confidence The document is titled as a detailed equity change report (详式权益变动报告书) for 紫光古汉集团股份有限公司, with a financial advisor's verification opinion from 中德证券有限责任公司. It references specific Chinese securities laws and regulations related to equity changes and acquisitions, such as the 《上市公司收购管理办法》 and disclosure standards 《准则15号》 and 《准则16号》. The content includes detailed due diligence, verification of the equity change purpose, funding sources, authorization procedures, and impact analysis on the listed company. It is a comprehensive report on a significant equity change transaction, not merely an announcement or a brief summary. The document length (12,626 characters) and detailed content confirm it is the full report itself, not just an announcement or certification. Therefore, the document fits the category of a detailed equity change report, which corresponds to the category "Major Shareholding Notification" (MRQ) in the provided classification scheme, as it deals with changes in significant share ownership levels crossing thresholds.
2015-10-08 Chinese
关于对全资子公司增资的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding an increase in capital investment into a wholly-owned subsidiary by injecting a state-owned land use right asset. It details the investment object, the subsidiary's basic information, and the purpose and impact of the investment. The document is relatively short (1046 characters) and is an announcement of a capital transaction rather than a full financial report or detailed financial data. It does not contain financial statements or comprehensive financial analysis. Therefore, it fits the category of Capital/Financing Update (CAP).
2015-10-08 Chinese
第七届监事会第四次会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of resolutions from the Supervisory Board meeting of 紫光古汉集团股份有限公司 held on October 8, 2015. It discusses the company's non-public issuance of shares, including the issuance plan, pricing, subscription details, use of proceeds, and related party transactions. The document includes voting results and mentions that some matters require shareholder approval. The content focuses on the company's capital raising activities through a non-public stock issuance, with detailed terms and conditions. This fits the definition of a Capital/Financing Update (CAP), as it provides updates on the company's fundraising and capital structure changes. The document is not a full financial report, audit, or regulatory filing, but a formal announcement of financing decisions and plans. The length (5057 characters) and detailed content confirm it is not a mere announcement of a report but a substantive update on financing.
2015-10-08 Chinese
关于无需编制前次募集资金使用情况报告的说明
Regulatory Filings Classification · 95% confidence The document is a brief announcement from the board of directors stating that the company is not required to prepare a report on the use of previously raised funds because the funds were raised more than five years ago. It references regulatory provisions but does not contain any financial data or detailed report content. The document length is very short (312 characters), and it serves as a regulatory compliance statement rather than a full report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2015-10-08 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.